Scott Rocklage is a well-known entrepreneur and has remarkable experience working in the management levels of various industries that are associated with pharmaceutical products. His love for scientific innovations and medical research is what has earned him his over 30 years of experience in the field.


Rocklage has held various management positions over the years, which enabled him to gain the approval of the FDA to use some of the drugs that he invented. These drugs include Omniscan, Telescan, and Cubicin. He also got the opportunity to get six candidates for testing to see just how well the drugs would work. The records that Dr. Scott Rocklage has set in his life have not only jolted his life forward but have also gained him prominence.


Scott was part of the founding managing partners at 5AM Ventures. From July 1994-March 2001 he was serving as the chief executive officer and president of cubist pharmaceuticals incorporation, and he served as its founding CEO from July 1994-June 2003. He also served as the president of Amersham Health.


Rocklage is currently serving as the board chairman of Rennovia, a pharmaceutical company. He is also the chair of Achaogen and Relypsa; he is on the board of waveRx and pulmatrix as well as on the board of associates at the Whitehead Institute.


His experience in being an entrepreneur has also come with some challenges as well as some good things. The challenge that he has faced has been that of hiring the wrong people, but this he says can be easily rectified. He considers that the best way to start your day is early. This is why he chose to name his company 5AM ventures. His piece of advice to entrepreneurs is that one shouldn’t be afraid to take a risk and that one should also not overstretch the business’ resources.


Scott Rocklage has had a huge number of peer-viewed publications. He has also been able to assist in various inventions on over 30 US patents. Scott says that the most exciting thing about science is the everyday discovery of things that make treatment of illnesses easier and the never-ending process of learning.


To learn more, visit

Leave a Reply

Your email address will not be published. Required fields are marked *